Spring Bank Pharmaceuticals, Inc.
Spring Bank Pharmaceuticals, Inc. (SBPH) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 119 transactions totaling $2.6M, demonstrating a bullish sentiment with $2.5M in net insider flow. The most recent transaction on Nov 20, 2020 involved a sale of 175 shares valued at $833.
SBPH Insider Activity Summary
Who Is Buying SBPH Stock?
No significant insider buying has been recorded for SBPH in the recent period.
Who Is Selling SBPH Stock?
No significant insider selling has been recorded for SBPH in the recent period.
Is Spring Bank Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SBPH is bullish with an Insider Alignment Score of 98/100 and a net flow of $2.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SBPH Frequently Asked Questions
Understanding SBPH Insider Activity
Insider trading at Spring Bank Pharmaceuticals, Inc. (SBPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading SBPH stock, having executed 119 transactions in the past 90 days. The most active insider is Kurt M. Eichler (Executive), who has made 30 transactions totaling $3.1M.
Related Tools
Track Spring Bank Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SBPH file new Form 4 transactions